Cite
HARVARD Citation
Germain, V. et al. (2020). Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect. Annals of the rheumatic diseases. 79 (1), p. e11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Germain, V. et al. (2020). Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect. Annals of the rheumatic diseases. 79 (1), p. e11. [Online].